Concepedia

Julie Locklear

JL

Statistics

Publications

15

Citations

1.1K

H-Index

13

Active since

2001

Affiliations

AstraZeneca (United States)(Current)

Wilmington University

AstraZeneca (Sweden)

Janssen (United States)

United BioSource Corporation (United Kingdom)

Julie Locklear is an author at AstraZeneca (United States) specializing in psychiatry, psychopharmacology, and pharmacy.

Publications per year

2001–2014

15

Publications

15

Partial Compliance and Risk of Rehospitalization Among California Medicaid Patients With Schizophrenia

Peter J. Weiden, Chris M Kozma, Amy Grogg et al. · Psychiatric Services · 2004 · 624 citations

, , +16

Assessment of compliance with antipsychotic treatmentand resource utilization in a medicaid population

Michael Eaddy, Amy Grogg, Julie Locklear · Clinical Therapeutics · 2005 · 109 citations

, , +14

Cost effectiveness of long-acting risperidone injection versus alternative antipsychotic agents in patients with schizophrenia in the USA

Natalie C. Edwards, Julie Locklear, Marcia F.T. Rupnow et al. · PharmacoEconomics · 2005 · 67 citations

, , +16

Assessing health-related quality of life in generalized anxiety disorder using the Quality Of Life Enjoyment and Satisfaction Questionnaire

Kathleen W. Wyrwich, Neesha Harnam, Dennis A. Revicki et al. · International Clinical Psychopharmacology · 2009 · 51 citations

, , +17

Different Approaches To Valuing the Lost Productivity of Patients with Migraine

Jennifer H. Lofland, Julie Locklear, Kevin D. Frick · PharmacoEconomics · 2001 · 48 citations

, , +11

1–5 of 15